Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive

NCT04249739 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Pembrolizumab

Sponsor

Samsung Medical Center